Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis.
about
Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes PathogenesisImpact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trialsThe microbial-mammalian metabolic axis: a critical symbiotic relationshipNon-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of AtherosclerosisFlavin-Containing Monooxygenase 3 Reduces Endoplasmic Reticulum Stress in Lipid-Treated HepatocytesMicrobial-Host Co-metabolites Are Prodromal Markers Predicting Phenotypic Heterogeneity in Behavior, Obesity, and Impaired Glucose ToleranceGenetic Variation in Choline-Metabolizing Enzymes Alters Choline Metabolism in Young Women Consuming Choline Intakes Meeting Current Recommendations.Role of Insulin in the Regulation of Proprotein Convertase Subtilisin/Kexin Type 9.Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis RiskDiets high in resistant starch increase plasma levels of trimethylamine-N-oxide, a gut microbiome metabolite associated with CVD risk.Emerging roles of flavin monooxygenase 3 in cholesterol metabolism and atherosclerosisTargeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery.Insulin Dissociates the Effects of Liver X Receptor on Lipogenesis, Endoplasmic Reticulum Stress, and Inflammation.Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans.Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic BurdenDioxin-like pollutants increase hepatic flavin containing monooxygenase (FMO3) expression to promote synthesis of the pro-atherogenic nutrient biomarker trimethylamine N-oxide from dietary precursors.Circulating MiRNA biomarkers serve as a fingerprint for diabetic atherosclerosisIntestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart FailureAssociations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional studyTrimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease.Genetic Variant in Flavin-Containing Monooxygenase 3 Alters Lipid Metabolism in Laying Hens in a Diet-Specific Manner.Trimethylamine N-Oxide and Mortality Risk in Patients With Peripheral Artery DiseaseDiet and Gut Microbial Function in Metabolic and Cardiovascular Disease Risk.miRNA and cholesterol homeostasis.The complex metabolism of trimethylamine in humans: endogenous and exogenous sources.Intestinal phospholipid and lysophospholipid metabolism in cardiometabolic disease.Microbiome, trimethylamine N-oxide, and cardiometabolic disease.Emerging roles of xenobiotic detoxification enzymes in metabolic diseases.Regulated methionine oxidation by monooxygenases.Canonical microRNAs Enable Differentiation, Protect Against DNA Damage, and Promote Cholesterol Biosynthesis in Neural Stem Cells.Flavin-containing monooxygenases in aging and disease: Emerging roles for ancient enzymes.EPRS is a critical mTORC1-S6K1 effector that influences adiposity in mice.Gut Microbiota-Dependent Trimethylamine-N-oxide and Serum Biomarkers in Patients with T2DM and Advanced CKD.Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus.The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue.Inactivation mechanism of N61S mutant of human FMO3 towards trimethylamine.Changes in Gut Microbiota-Related Metabolites and Long-term Successful Weight Loss in Response to Weight-Loss Diets: The POUNDS Lost Trial.Fructose and glucose regulate mammalian target of rapamycin complex 1 and can activate lipogenic gene expression via distinct pathways.
P2860
Q26823198-7D27CF49-E497-46A2-8915-E89362C1BC88Q28077742-35303633-C0BD-4FC7-A6D4-7FA4657C697FQ28828859-41A8CFA4-36A9-423C-9654-27D213F7DA6AQ29038812-50F4E0AF-AC3B-47BC-96EE-9820415847C4Q33631394-6FD99E58-2F66-42B4-8379-EFCA4707AE92Q33899037-1A1645B9-6E12-41CB-8E9A-0720348B38D3Q34680631-046AB0D6-F6F3-4668-BBEC-83BD54D5AD47Q35794774-D29054B0-6C4A-44C8-9471-0A9F82BA997DQ35955435-0CD65553-8C8E-47B8-BC02-20C3A3860D95Q36228851-EA83EB51-C62F-4D28-8D25-D779A995A81FQ36337990-C046F535-65D0-4A05-B17E-D3E61249104EQ36340545-94F37F0E-8647-4DA4-BAAE-0B2C877711A5Q36466124-929CA03B-A245-459D-BC13-FBFF46E9A89DQ36827878-3CB54092-4BB0-49FF-9251-C1653F17C53FQ36941666-6C07181E-36A6-4BBE-A24F-0836984ADA0DQ36968992-30332B5C-D699-46D0-B3E3-F5FDA92683C7Q36971248-F1690B85-9BBF-498A-9A80-C8D4748AD80FQ37060780-2814BB11-C07F-402D-9AFB-5297FFE45931Q37076037-EA15762D-F241-4F11-AD30-1B4C37F793A4Q37090184-B797E25D-B363-425A-A3F0-E8CF35223F5DQ37310131-6A982A59-E283-4639-A75B-C30362569393Q37357727-72BFF3D5-96C1-4A5C-9039-790B2E8FBDEAQ37428179-8B128CEE-D4E9-4D8C-BDB3-14C9E06C8402Q37434802-6B1DE8A6-52B4-4FBF-9C59-7FDEE388D4C4Q37595816-3FEDAE9E-5AD2-4347-8868-597E39B7BE63Q38700512-96DE758E-B445-4491-9FA0-DBBAF1AF2B21Q38820418-FA8C420C-E2E4-4D87-A209-05E8B4B5AB11Q38903367-47141FD7-C39A-412D-A782-95106CB52EA2Q38918147-6E728DE7-4B27-4122-AE81-6E7CE0F6EEB7Q39006153-AA8C2B6D-4B4A-442A-B961-EE9AC6C64E6FQ39147645-1C07BC2F-097B-4FCA-8B58-4DD46ED0B828Q39267584-C34C8E2A-3EAA-4959-93E5-CEC6432BB762Q39313594-3FAA1AD7-E1E4-49E1-884A-D03ED7A68C1FQ41068541-9DA7F3CB-B3FE-4E5E-87C0-672FE5EF6448Q41674747-1EDFA0ED-76F6-480D-95CE-146F0F0E660EQ42616677-4B912038-A07D-4E60-A7B1-1E67437300B0Q45061812-DBF692F1-29A0-4D03-8FF3-C67164BB9424Q47107145-17C3C890-2E89-467A-822E-AD3CE2540DCCQ47172271-3704A831-88B4-4F14-9A90-7E17B9976113Q47340121-1C6E567C-65A5-4CF7-89AE-84304494A43B
P2860
Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Flavin-containing monooxygenas ...... es-associated atherosclerosis.
@ast
Flavin-containing monooxygenas ...... es-associated atherosclerosis.
@en
type
label
Flavin-containing monooxygenas ...... es-associated atherosclerosis.
@ast
Flavin-containing monooxygenas ...... es-associated atherosclerosis.
@en
prefLabel
Flavin-containing monooxygenas ...... es-associated atherosclerosis.
@ast
Flavin-containing monooxygenas ...... es-associated atherosclerosis.
@en
P2093
P2860
P356
P1476
Flavin-containing monooxygenas ...... es-associated atherosclerosis.
@en
P2093
Alisha V Ling
David Vicent
Kevin J Croce
Mark J Graham
Mary E Gearing
Morbid Obesity Study Group
Praveen V Manthena
Rosanne M Crooke
Ryan M Esquejo
P2860
P2888
P356
10.1038/NCOMMS7498
P407
P577
2015-04-07T00:00:00Z
P5875
P6179
1046591711